Ticker	Volume	Price	Price Delta
DJIA	15,295.30	-22.96	-0.15%
S&P 500	1,649.84	-1.97	-0.12%
Nasdaq	3,467.04	-15.14	-0.43%

Ticker

Volume

Price

Price Delta

DJIA

15,295.30

-22.96

-0.15%

S&P 500

1,649.84

-1.97

-0.12%

Nasdaq

3,467.04

-15.14

-0.43%

Ticker	Volume	Price	Price Delta
STOXX 50	2,683.98	-16.95	-0.63%
FTSE 100	6,348.82	-25.39	-0.40%
DAX	8,197.08	-32.43	-0.39%

Ticker

Volume

Price

Price Delta

STOXX 50

2,683.98

-16.95

-0.63%

FTSE 100

6,348.82

-25.39

-0.40%

DAX

8,197.08

-32.43

-0.39%

Ticker	Volume	Price	Price Delta
Nikkei	13,245.20	+237.94	1.83%
Hang Seng	20,986.90	-238.99	-1.13%
S&P/ASX 200	4,861.38	+47.03	0.98%

Ticker

Volume

Price

Price Delta

Nikkei

13,245.20

+237.94

1.83%

Hang Seng

20,986.90

-238.99

-1.13%

S&P/ASX 200

4,861.38

+47.03

0.98%

Exchange: NASDAQ GS
Sector: Health Care
Industry: Medical Equipment/Devices
Sub-Industry: Medical Equipment

Hologic Inc

+ Add to Watchlist

HOLX:US

20.7800 USD 0.2600 1.24%

Share this quote:

Post this quote on one of these sites:

Copy permanent URL

As of 13:50:19 ET on 06/19/2013.

News for Hologic Inc (HOLX)

COMPANY NEWS
PRESS RELEASES
INDUSTRY NEWS

FDA REPORT WEIGHING TOUGHER RESTRICTIONS FOR FLU TESTS Published Jun 11, 2013
Quest Diagnostics and Hologic Form Strategic Alliance to Improve Women's Health Published Jun 06, 2013
DiagnoCure announces second quarter 2013 results Published Jun 03, 2013
Data From a New Study on Diagnocure's GCC Assay Show Positive Results for Predicting Risk of Colon Cancer Recurrence Published Jun 03, 2013
The Zacks Analyst Blog Highlights: PowerShares DB US Dollar Index Bullish, CurrencyShares Japanese Yen Trust, CurrencyShares Published May 30, 2013
DiagnoCure to host Q2 2013 earnings conference call and webcast Published May 28, 2013
Hologic Receives FDA Approval for a New Low-dose 3D Mammography (Breast Tomosynthesis) Solution for Breast Cancer Screening Published May 28, 2013
First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Published May 23, 2013
Medistem, Inc. Appoints Herm Rosenman to Board of Directors Published May 21, 2013
Hologic Receives FDA Approval for a New Low-dose 3D Mammography (Breast Tomosynthesis) Solution for Breast Cancer Screening Published May 21, 2013

No news stories found.

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Hologic Inc

HOLX:US

Share this quote:

News for Hologic Inc (HOLX)

COMPANY NEWS

PRESS RELEASES

INDUSTRY NEWS

Bloomberg.com

About

Support and Contact

Stay Connected

Bloomberg Terminal

Bloomberg Premium Services

Mobile Apps

Hologic Inc

HOLX:US

Share this quote:

News for Hologic Inc (HOLX)

COMPANY NEWS

PRESS RELEASES

INDUSTRY NEWS

Bloomberg.com

About

Support and Contact

Stay Connected

Bloomberg Terminal

Related Bloomberg Sites

Bloomberg Premium Services

Mobile Apps